866545-96-2

Basic information

• Product Name: 1-(5-Bromo-7-azaindole)ethanone
• Synonyms: 1-(5-Bromo-7-azaindole)ethanone;1-(5-BROMO-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-ETHANONE;Ethanone, 1-(5-broMo-1H-pyrrolo[2,3-b]pyridin-3-yl)-;1-{5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl}ethan-1-one
• CAS NO: 866545-96-2
• Molecular Formula: C₉H₇BrN₂O
• Molecular Weight: 239.06868
• Mol File: 866545-96-2.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Density: 1.674±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 11.29±0.40(Predicted)
• CAS DataBase Reference: 1-(5-Bromo-7-azaindole)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-Bromo-7-azaindole)ethanone(866545-96-2)
• EPA Substance Registry System: 1-(5-Bromo-7-azaindole)ethanone(866545-96-2)

Safety Data

• Hazardous Substances Data: 866545-96-2(Hazardous Substances Data)

Usage

General Description

1-(5-Bromo-7-azaindole)ethanone, also known as 5-Bromo-7-azaindole-1-carboxylic acid ethyl ester, is a chemical compound with the molecular formula C9H7BrN2O. It is a derivative of azaindole, a heterocyclic organic compound, and is commonly used in pharmaceutical research and drug development. The compound is known for its potential as a building block in the synthesis of various biologically active molecules, and it has been studied for its potential as a precursor to new drugs. Its structure and properties make it a valuable tool for medicinal chemistry and drug discovery research. It is important to handle and use this compound with care, as it may pose health or environmental hazards.

Upstream product

• 75-36-5 acetyl chloride 
• 183208-35-7 5-bromo-1H-pyrrolo[2,3-b]pyridine 

Downstream Products

• 875639-40-0 5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1-(toluene-4-sulfonyl)-3-[2-(toluene-4-sulfonyl)-2H-pyrazol-3-yl]-1H-pyrrolo[2,3-b]pyridine 
• 875639-39-7 5-bromo-1-(toluene-4-sulfonyl)-3-[2-(toluene-4-sulfonyl)-2H-pyrazol-3-yl]-1H-pyrrolo[2,3-b]pyridine 
• 1071454-96-0 1-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl-1-2(2-trimethylsilanyl-ethoxymethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-ethanone] 
• 1052633-38-1 1-(5-bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone 
• 1256819-54-1 5-bromo-3-isopropyl-1H-pyrrolo[2,3-b]pyridine 
• 1620574-97-1 5-bromo-3-isopropyl-1-tosyl-1H-pyrrolo[2,3-b]pyridine 
• 1620574-96-0 2-(5-bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)propan-2-ol 

Relevant articles and documents

TRICYCLIC DLK INHIBITORS AND USES THEREOF

The invention relates to compounds of formula (I) and salts thereof, wherein ring A and R1-R2 have any of the values defined in the specification. The compounds and salts are useful for treating DLK mediated disorders. The invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, as well as methods of using said compounds, salts, or compositions as DLK inhibitors and for treating neurodegeneration diseases and disorders.

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

A compound represented by formula (I) having mTOR inhibitory activity or a pharmacologically acceptable salt thereof.

PYRROLO-PYRIDINE KINASE MODULATORS

The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.